Citadel Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-917
Closed -$22.6K – 14596
2024
Q4
$22.6K Buy
917
+567
+162% +$24.7K ﹤0.01% 13100
2024
Q3
$18.9K Buy
+350
New +$18.7K ﹤0.01% 12818
2023
Q2
– Sell
-283
Closed -$14.3K – 14434
2023
Q1
$14.3K Buy
+283
New +$16.7K ﹤0.01% 13321
2022
Q3
– Sell
-1,125
Closed -$89K – 12722
2022
Q2
$89K Hold
1,125
– – ﹤0.01% 11514
2022
Q1
$169K Sell
1,125
-850
-43% -$126K ﹤0.01% 11711
2021
Q4
$335K Buy
+1,975
New +$397K ﹤0.01% 10680
2021
Q3
– Sell
-800
Closed -$248K – 13867
2021
Q2
$248K Buy
+800
New +$250K ﹤0.01% 11706

Other funds holding CNBS

Citadel Advisors's CNBS Position: Q2 2026 in Review

Citadel Advisors increased its Amplify Seymour Cannabis ETF (CNBS) stake by 27% in Q2 2026, buying an estimated $109K and bringing the position to 18,751 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #9627.

Citadel Advisors first reported a position in CNBS in Q2 2021 and has held it in 6 quarters since. 16 funds tracked by Wall St. Rank hold CNBS as of Q2 2026.

  • Citadel Advisors held 18,751 shares of Amplify Seymour Cannabis ETF worth $548K as of Q2 2026.
  • Citadel Advisors bought 3,963 Amplify Seymour Cannabis ETF shares in Q2 2026, an estimated $109K.
  • Amplify Seymour Cannabis ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9627 holding.
  • Citadel Advisors first reported a position in Amplify Seymour Cannabis ETF in Q2 2021 and has held it in 6 quarters since.
  • 16 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.